Answer
Sorafenib tosilate has been shown to prolong the QT/QTc interval, which may increase the risk of ventricular arrhythmias.
Sources for this answer
- Nexavar 200mg film-coated tabletsBayer plc · emc · SmPC §4.4 Special warnings and precautions for use · Version 32Document updated
Sources checked